Cite
Dosimetric and Clinical Predictors of Nausea and Vomiting: An Exploratory Analysis of a Prospective Phase I/II Trial With Neoadjuvant Accelerated Short Course Radiation Therapy With Capecitabine for Resectable Pancreatic Cancer
MLA
Tseng, Y. D., et al. “Dosimetric and Clinical Predictors of Nausea and Vomiting: An Exploratory Analysis of a Prospective Phase I/II Trial With Neoadjuvant Accelerated Short Course Radiation Therapy With Capecitabine for Resectable Pancreatic Cancer.” International Journal of Radiation Oncology, Biology, Physics, vol. 84, Nov. 2012, pp. S321–22. EBSCOhost, https://doi.org/10.1016/j.ijrobp.2012.07.843.
APA
Tseng, Y. D., Wo, J. Y., Ancukiewicz, M., Adams, J., Panahandeh, H., Depauw, N., & Hong, T. S. (2012). Dosimetric and Clinical Predictors of Nausea and Vomiting: An Exploratory Analysis of a Prospective Phase I/II Trial With Neoadjuvant Accelerated Short Course Radiation Therapy With Capecitabine for Resectable Pancreatic Cancer. International Journal of Radiation Oncology, Biology, Physics, 84, S321–S322. https://doi.org/10.1016/j.ijrobp.2012.07.843
Chicago
Tseng, Y.D., J.Y. Wo, M. Ancukiewicz, J. Adams, H. Panahandeh, N. Depauw, and T.S. Hong. 2012. “Dosimetric and Clinical Predictors of Nausea and Vomiting: An Exploratory Analysis of a Prospective Phase I/II Trial With Neoadjuvant Accelerated Short Course Radiation Therapy With Capecitabine for Resectable Pancreatic Cancer.” International Journal of Radiation Oncology, Biology, Physics 84 (November): S321–22. doi:10.1016/j.ijrobp.2012.07.843.